2010 - TTS International Congress


This page contains exclusive content for the member of the following sections: TTS. Log in to view.

Complications Metabolic

32.8 - Renal Tubular Acidosis after Kidney Transplantation

Presenter: Esra, Baskin, Ankara, Turkey
Authors: Baskin E., Bayrakci U., Gulleroglu K., Melek E., Sevmis S., Karakayali H., Haberal M.

RENAL TUBULAR ACIDOSIS AFTER KIDNEY TRANSPLANTATION

COMPLICATIONS - METABOLIC

E. Baskin1, U.S. Bayrakci1, K. Gulleroglu1, E. Melek1, S. Sevmis2, H. Karakayali2, M. Haberal2
1Pediatric Nephrology, Baskent University, Ankara/TURKEY, 2General Surgery And Transplantation, Baskent University, Ankara/TURKEY

Body: Long term renal transplant recipients with adequate graft function develop post-transplant renal tubular acidosis (RTA). However, neither the prevalence nor the associated risk factors of late post-transplant RTA are known. Although calcineurin inhibitors (CNI), suboptimal allograft function, donor age and acute rejection have been associated with RTA, no detailed study has been conducted to investigate the prevalence and clinical implications of RTA in long-term kidney recipients. METHODS: In this cross-sectional study, we enrolled 44 patients (M/F:20/24) for the study. The mean age of patients was 15.8±5 years and the median duration of follow-up was 17.5 months. Patients with glomerular filtration rate (GFR) <30 ml/min/1.73 m², unstable allograft function, diarrhea, and respiratory disease were excluded. RTA was diagnosed on the basis of low arterial bicarbonate (<22 mEq/l) and pH (<7.37) together with normal serum anion gap and positive urine anion gap. RESULTS: Nineteen patients (43.2%) were found to have RTA on the basis of plasma bicarbonate, arterial pH, and urine and serum anion gap measurements. GFR was found to be lower in patients with RTA (74±22.3 in RTA and 102.6±34.4 ml/min/1.73 m² in non-RTA, P = 0.003). Uric acid and creatinine levels were found to be higher in the RTA group (uric acid: 5.8±1.5 mg/dl vs. 4.5±1.6 mg/dl, p=0.02, creatinine: 1.1±0.38 mg/dl vs. 0.78±0.33 mg/dl, p=0.001), while no difference was noticed in body mass index, CRP or serum albumin. Parathyroid hormone levels were also found to be significantly higher in patients with RTA (93.3±54.3 ng/dl vs. 58.5±23.8 ng/dl, p=0.01). Analysis of the prevalence of osteoporosis and osteopenia in patients with RTA and without RTA, respectively, revealed no difference in frequency of osteoporosis (42% vs. 52%) or osteopenia (31.6% vs. 36%). We also did not find any relation between renal tubular acidosis and immunosuppressive regimen or trough levels of CNI. CONCLUSION: Although long-term kidney recipients have a relatively high prevalence of RTA, it is usually mild and subclinical. Further studies are needed to clarify long-term effects of RTA in kidney recipients.

Disclosure: All authors have declared no conflicts of interest.


Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Social

Contact

Staff Directory
+1-514-874-1717
info@tts.org

Address

The Transplantation Society
International Headquarters
740 Notre-Dame Ouest
Suite 1245
Montréal, QC, H3C 3X6
Canada